Search results for: Maria Lowe
Filter search results
Trade and Price Differentials for Pharmaceuticals: Policy Options
1 May 1997
…reflecting differences in regulation and other factors. In recent years, governments are increasingly attempting to take advantage of lower prices abroad to control pharmaceutical expenditures under their own national health…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…and society: Key takeaways Enhanced Patient Outcomes: Long-acting (LA) therapies have potential to improve treatment adherence and clinical outcomes by reducing dosing frequency, thereby lowering treatment burden and minimising symptom…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
…written by Panagiotis Kasteridis, Anne Mason, Maria Goddard, Rowena Jacobs, Rita Santos, Beatriz Rodriguez-Sanchez, all of the University of York. The title of the paper was “Care home placement following…
Ethical and Economic Issues in the Appraisal of Medicines for Ultra-rare (or Ultra-orphan) Conditions
13 January 2020
…under the HST process could lead to inequalities in access and health outcomes for patients with ultra-rare conditions. A new OHE Consulting Report by Nadine Henderson, Maria Errea, Chris Skedgel,…
OHE Thanks Trustees for Their Service
17 December 2021
…at ISPOR Barcelona, Lou shared a quote from Marian Wright Edelman “You can’t be what you can’t see.” Our team is 63% female and representation on both the executive and…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…Impact) asked what policies would support the sectors most critical in driving innovation. Maria Lamas (Spanish Agency for Medicines and Medical Devices) suggested finding the right balance between ensuring optimised…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
US policy makers are discussing an attempt to lower prescription drug spending in the US. US policy makers are currently discussing the Elijah E. Cummings Lower Drug Costs Now Act…
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
…in lower use in the UK. This Report is based on both a… Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether…
Drug shortages are on the rise – but what is their impact?
16 September 2024
…around the world: increasing pressure to lower prices of generic and biosimilar medicines, versus the rising tide of drug shortages. As our previous research (Napier et al., 2024) identified, drug…